SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK
14-06-2026 15:36 via prnewswire.com

SAMARITAN'S PURSE EBOLA TREATMENT CENTERS OPEN IN THE EPICENTER OF THE DEADLY OUTBREAK

BOONE, N.C., June 14, 2026 /PRNewswire/ -- Samaritan's Purse has established two Ebola Treatment Centers in Bunia and Nyankunde, Democratic Republic of Congo (DRC), to care for patients suffering from the deadly Ebola virus. These facilities are specially outfitted emergency field...
Read more »

PR Public relations news



Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Empyrean Anaheim Resort, Inc., for Alleged Failure to Provide Required Meal Periods and Rest Periods
Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against Empyrean Anaheim Resort, Inc., for Alleged Failure to Provide Required Meal Periods and Rest Periods
Phreesia Deadline: PHR Investors with Losses in Excess of $100K Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit
Phreesia Deadline: PHR Investors with Losses in Excess of $100K Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit
Concept Study Identifies Potential Refining Pathway at Shaakichiuwaanaan to Battery-Grade Lithium Carbonate
Concept Study Identifies Potential Refining Pathway at Shaakichiuwaanaan to Battery-Grade Lithium Carbonate
GeneDx Holdings Corp. (WGS) Class Action Lawsuit: Investors Face August 3, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
GeneDx Holdings Corp. (WGS) Class Action Lawsuit: Investors Face August 3, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP
Die Menarini Group präsentiert auf dem Kongress der European Hematology Association (EHA) 2026 Daten aus der Phase-3-Studie SENTRY zur Kombination von Selinexor und Ruxolitinib bei Myelofibrose
Die Menarini Group präsentiert auf dem Kongress der European Hematology Association (EHA) 2026 Daten aus der Phase-3-Studie SENTRY zur Kombination von Selinexor und Ruxolitinib bei Myelofibrose
Muscle Growth Supplements Featuring Magnesium, Ashwagandha and Omega-3s Are Highlighted by PureHealth Research
Muscle Growth Supplements Featuring Magnesium, Ashwagandha and Omega-3s Are Highlighted by PureHealth Research
Orbis International's Flying Eye Hospital Arrives in Peru to Expand Access to Essential Eye Care
Orbis International's Flying Eye Hospital Arrives in Peru to Expand Access to Essential Eye Care
Tradr to Ring Opening Bell at Cboe to Celebrate SpaceX ETF Launches
Tradr to Ring Opening Bell at Cboe to Celebrate SpaceX ETF Launches
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
RiderNav presenta sus pantallas inteligentes de 7 pulgadas para motocicletas en el Mid-Summer Riding Festival
RiderNav presenta sus pantallas inteligentes de 7 pulgadas para motocicletas en el Mid-Summer Riding Festival
AFX accelera l'espansione globale guidata dall'esperto del settore Ken C
AFX accelera l'espansione globale guidata dall'esperto del settore Ken C
AFX beschleunigt globale Expansion mit Branchenveteran Ken C als Leiter für Wachstum
AFX beschleunigt globale Expansion mit Branchenveteran Ken C als Leiter für Wachstum
AFX accélère son expansion mondiale sous la houlette de Ken C pour mener à bien sa croissance
AFX accélère son expansion mondiale sous la houlette de Ken C pour mener à bien sa croissance
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Desktop versie